Active, Not Recruiting
Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell Carcinoma
NCT04869137
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +20 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States